a comparative study followed , comprising 20 patients randomly assigned to receive isradipine ( starting at 0.6 microgram/kg/minute ) or nitroprusside ( initially 1 microgram/kg/minute ) for the treatment of post-aortocoronary bypass graft hypertension .
C0071304
isradipine
C0020538
hypertension